Agnes Fromont

Dijon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial.

High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial.

Journal: JAMA

Published: March 10, 2025

Anti-Argonaute antibodies as a potential biomarker in NMOSD.

Anti-Argonaute antibodies as a potential biomarker in NMOSD.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 08, 2022

A rare double diagnosis identified via exome sequencing in a patient with complex cerebellar ataxia: a case report.

A rare double diagnosis identified via exome sequencing in a patient with complex cerebellar ataxia: a case report.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 10, 2022

Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E -Mutated Erdheim-Chester Disease: A Case Report.

Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E -Mutated Erdheim-Chester Disease: A Case Report.

Journal: Frontiers in immunology

Published: May 11, 2022

Multiple sclerosis

Multiple sclerosis

Journal: La Revue du praticien

Published: September 03, 2020

High efficiency and clinical relevance of exome sequencing in the daily practice of neurogenetics.

High efficiency and clinical relevance of exome sequencing in the daily practice of neurogenetics.

Journal: Journal of medical genetics

Published: July 24, 2020

Interferences of biotin therapy on immunoassays: It is time for a long-term solution!

Interferences of biotin therapy on immunoassays: It is time for a long-term solution!

Journal: Presse medicale (Paris, France : 1983)

Published: July 21, 2017

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 28, 2016

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.

Journal: Neurology

Published: April 12, 2016

Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors.

Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors.

Journal: The Journal of steroid biochemistry and molecular biology

Published: November 28, 2015

Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.

Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.

Journal: The Journal of steroid biochemistry and molecular biology

Published: October 31, 2015

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Journal: Multiple sclerosis and related disorders

Published: July 27, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026